Khaled A Tolba

Title: Khaled A Tolba: Innovator in Herpesvirus Research

Introduction

Khaled A Tolba is a prominent inventor based in Rochester, NY (US). He has made significant contributions to the field of immunotherapy through his innovative research and patents. His work focuses on developing new methods for creating herpesvirus amplicon particles that can be utilized in treating various infectious diseases and cancers.

Latest Patents

Khaled A Tolba holds a patent for "Helper virus-free herpesvirus amplicon particles and uses thereof." This invention features novel helper virus-free methods for producing herpesvirus amplicon particles. These particles have potential applications in immunotherapies for treating chronic lymphocytic leukemia and other malignancies, including lymphomas. The patent describes methods for creating these particles, the cells that contain them, and the treatment methods involving these particles.

Career Highlights

Khaled A Tolba is affiliated with the University of Rochester, where he conducts his research. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from various cancers and infectious diseases. His innovative approach to herpesvirus amplicon particles showcases his commitment to advancing medical science.

Collaborations

Khaled A Tolba has collaborated with notable colleagues, including Howard J Federoff and William J Bowers. These collaborations have further enriched his research and contributed to the development of groundbreaking therapies.

Conclusion

Khaled A Tolba is a distinguished inventor whose work in herpesvirus research has the potential to impact the field of immunotherapy significantly. His innovative methods and dedication to advancing medical treatments highlight the importance of research in improving patient outcomes.